Modified enzyme which target to neuronal cells to cross blood brain barrier
修饰酶靶向神经元细胞穿过血脑屏障
基本信息
- 批准号:02557042
- 负责人:
- 金额:$ 3.26万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Developmental Scientific Research (B)
- 财政年份:1989
- 资助国家:日本
- 起止时间:1989 至 1990
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
MODIFIED ENZYME WHICH TARGFRS TO NEURONAL CELLS TO CROSS BLOOD BRAIN BARRIERWe tried to prepare modified placental glucocerebrosidase treated with neuraminidase and galactosidase and mumose terminal glucocerebrosidase was injected intravenously into mouse. We chased enzyme activities of glucocerebrosidase in mouse brain, Ever, kidney and other tissues. The maximum activity of the enzyme was obtkned after 15 minute injection, and significant staining of-enzyme-activity was found in the brain. These data suggest that mamose terminated enyzme could be useful for the treatment of neuronopathic Gaucher disease. Liposomes prepared from lecithincholesterol- aminophenylmwmoside (7 : 2 : 1) were efficiently incorporated into mouse brain across the blood brain barrier. Furthermore, hposomes injected intraperitoneauy were exclussively distributed into lysosome rich fraction and taken up by glial cells. These data suggest that blood brain barrier cells and glial cells recognize mannose and can be used for the treattnent of brain damage by lysosomat storage disease.
以神经氨酸酶和半乳糖苷酶为处理手段制备胎盘糖脑苷酶修饰物,并将其静脉注射小鼠。我们对小鼠脑、肝、肾等组织中葡萄糖脑苷酶的活性进行了测定。注射15分钟后酶活性达到最大值,脑内酶活性染色明显。这些数据提示乳腺终止酶可用于神经病变戈谢病的治疗。由卵磷脂-胆固醇-氨基苯基莫苷(7:2:1)制备的脂质体可通过血脑屏障有效地进入小鼠大脑。此外,腹腔注射的小体排他性地分布在富含溶酶体的部分,并被胶质细胞吸收。这些数据表明,血脑屏障细胞和神经胶质细胞能够识别甘露糖,并可用于治疗溶酶体储存病引起的脑损伤。
项目成果
期刊论文数量(33)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Kawame H.,Eto Y.: "A New Glucocerebrosidase-Gene Missense Mutation Responsible for Neuronopathic Gacher Disease in Japanese Datients." Am.J Hum Genet. 49. 1378-1380 (1991)
Kawame H.,Eto Y.:“一种新的葡萄糖脑苷脂酶基因错义突变导致日本患者的神经病性盖赫病。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Sugama S., Kim S. U., Ida H, and Eto Y.: "Psychosine cytotoxicity in rat neural cell cultures and protection by phorbol ester and olimethyl sulfoxide." Pediatr. Res.28. 473-476 (1990)
Sugama S.、Kim S. U.、Ida H 和 Eto Y.:“大鼠神经细胞培养物中的精神苷细胞毒性以及佛波酯和寡甲基亚砜的保护。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Tahara T., Kraus J. P. and Rosengerg L. E.: "Direct DNA sequencing of PCR amplified genomic DNA by the Maxam-Gilbert method." Bio Technique. 8. 366-368 (1990)
Tahara T.、Kraus J. P. 和 Rosengerg L. E.:“通过 Maxam-Gilbert 方法对 PCR 扩增的基因组 DNA 进行直接 DNA 测序。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Ida H,Eto Y.: "Biochemical and Morphological studies of dorsal root ganglion and its cultured from twitcher mouse." Brain and Develop.12. 412-416 (1990)
Ida H,Eto Y.:“背根神经节及其培养物的生化和形态学研究。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Y. Eto, F. Umezawa: "Iposomal therapy in lysosomal storage disease." Amer. J. Med. Genet.7. 85-88 (1989)
Y. Eto,F. Umezawa:“溶酶体贮积病的脂质体疗法。”
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ETO Yoshikatsu其他文献
ETO Yoshikatsu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ETO Yoshikatsu', 18)}}的其他基金
Anti-CD3 antibody induced immune tolerance to infused enzyme in enzyme replacement therapy for lysosomal storage disease
抗 CD3 抗体在溶酶体贮积病酶替代疗法中诱导对输注酶的免疫耐受
- 批准号:
21591333 - 财政年份:2009
- 资助金额:
$ 3.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Immune tolerance induction in enzyme replacement therapy for lysosomal storage diseases
溶酶体贮积病酶替代疗法中的免疫耐受诱导
- 批准号:
19591223 - 财政年份:2007
- 资助金额:
$ 3.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Development of novel therapy and elucidation of pathophysiology for genetic leukodystrophy
遗传性脑白质营养不良新疗法的开发和病理生理学的阐明
- 批准号:
14370252 - 财政年份:2002
- 资助金额:
$ 3.26万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Prenatal Diagnosis of Ingenited Metabolic Disorders Using Maternal Blood
利用母血对先天性代谢紊乱进行产前诊断
- 批准号:
11557061 - 财政年份:1999
- 资助金额:
$ 3.26万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular Pathogenesis of Brain Damage and Gene Therapy in Genetic Leukodystrophy
遗传性脑白质营养不良脑损伤的分子发病机制和基因治疗
- 批准号:
11470176 - 财政年份:1999
- 资助金额:
$ 3.26万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Studies for Gene Therapy of Sphingolipidosis
鞘脂沉积症基因治疗研究
- 批准号:
10044321 - 财政年份:1998
- 资助金额:
$ 3.26万 - 项目类别:
Grant-in-Aid for Scientific Research (B).
The cause of neuropathochemistry of inherited Neurodegeneration
遗传性神经变性的神经病理化学原因
- 批准号:
08457232 - 财政年份:1996
- 资助金额:
$ 3.26万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Pathogenesis of Multiple Sulfatase Deficiency
多种硫酸酯酶缺乏症的发病机制
- 批准号:
01570550 - 财政年份:1989
- 资助金额:
$ 3.26万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Molecular and biochemical analysis of inherited degernerative brain disorder
遗传性退行性脑部疾病的分子和生化分析
- 批准号:
61480223 - 财政年份:1986
- 资助金额:
$ 3.26万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
相似海外基金
ICF: Enhancing Blood-Brain Barrier Opening with Ultrasound and Microwaves for Targeted Drug Delivery
ICF:利用超声波和微波增强血脑屏障开放以实现靶向药物输送
- 批准号:
MR/Z503848/1 - 财政年份:2024
- 资助金额:
$ 3.26万 - 项目类别:
Research Grant
Development of blood-brain barrier-penetrating oligosaccharides
穿透血脑屏障寡糖的开发
- 批准号:
23K11852 - 财政年份:2023
- 资助金额:
$ 3.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Venom-derived blood-brain-barrier shuttles
毒液衍生的血脑屏障穿梭机
- 批准号:
DP230102707 - 财政年份:2023
- 资助金额:
$ 3.26万 - 项目类别:
Discovery Projects
Defining mechanisms of blood-brain barrier dysfunction in cerebral small vessel disease using advanced 3D in vitro models.
使用先进的 3D 体外模型定义脑小血管疾病血脑屏障功能障碍的机制。
- 批准号:
MR/W027119/1 - 财政年份:2023
- 资助金额:
$ 3.26万 - 项目类别:
Fellowship
Understanding suppression of transcytosis in formation of the blood-brain barrier (BBB) and how Calcrl/Ramp2 signalling limits BBB permeability
了解血脑屏障 (BBB) 形成过程中转胞吞作用的抑制以及 Calcrl/Ramp2 信号如何限制 BBB 通透性
- 批准号:
MR/X008215/1 - 财政年份:2023
- 资助金额:
$ 3.26万 - 项目类别:
Research Grant
Bisphenol-Induced Blood-Brain Barrier Dysfunction in Alzheimer’s Disease
双酚引起的阿尔茨海默氏病血脑屏障功能障碍
- 批准号:
10713025 - 财政年份:2023
- 资助金额:
$ 3.26万 - 项目类别:
The blood-brain barrier and Alzheimer pathology
血脑屏障和阿尔茨海默病病理学
- 批准号:
10800246 - 财政年份:2023
- 资助金额:
$ 3.26万 - 项目类别:
Circadian Rhythms in Blood Brain Barrier Permeability and Increased Efficacy of Chemotherapy for Brain Metastases
血脑屏障通透性的昼夜节律和脑转移化疗疗效的提高
- 批准号:
10663717 - 财政年份:2023
- 资助金额:
$ 3.26万 - 项目类别:
Blood brain barrier integrity and immune dynamics contributing to neuropsychiatric sequela in COVID long-haulers
血脑屏障完整性和免疫动态导致新冠长途运输者的神经精神后遗症
- 批准号:
10688300 - 财政年份:2023
- 资助金额:
$ 3.26万 - 项目类别:
MicroRNAs, Mitochondria and the Blood-Brain Barrier - Therapeutic Targets for Stroke
MicroRNA、线粒体和血脑屏障——中风的治疗靶点
- 批准号:
10587899 - 财政年份:2023
- 资助金额:
$ 3.26万 - 项目类别:














{{item.name}}会员




